ClearPoint Neuro (CLPT) EBT Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 2,644.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,644.00 |
| Dec 31, 2025 | 1,162.00 |
| Sep 30, 2025 | 735.00 |
| Jun 30, 2025 | 1,953.00 |
| Mar 31, 2025 | 810.00 |
| Dec 31, 2024 | 2,710.00 |
| Sep 30, 2024 | 2,730.00 |
| Jun 30, 2024 | 5,095.00 |
| Mar 31, 2024 | 828.00 |
| Dec 31, 2023 | -266.00 |
| Sep 30, 2023 | -4,313.00 |
| Jun 30, 2023 | -5,237.00 |
| Mar 31, 2023 | -3,931.00 |
| Dec 31, 2022 | -10,831.00 |
| Sep 30, 2022 | -3,536.00 |
| Jun 30, 2022 | -2,305.00 |
| Mar 31, 2022 | -2,931.00 |
| Dec 31, 2021 | -4,336.00 |
| Sep 30, 2021 | -796.00 |
| Jun 30, 2021 | 758.00 |
| Mar 31, 2021 | 4,080.00 |
| Sep 30, 2019 | 8,213.00 |
| Jun 30, 2019 | 15,650.00 |
| Mar 31, 2019 | 11,691.00 |
| Sep 30, 2018 | 10,490.00 |
| Jun 30, 2018 | 1.01 Mn |
| Mar 31, 2018 | 22,904.00 |
| Sep 30, 2016 | 686,770.00 |
| Jun 30, 2016 | 24,644.00 |
| Mar 31, 2016 | 159,781.00 |
| Sep 30, 2015 | -8,851.00 |
| Jun 30, 2015 | -981,721.00 |
| Mar 31, 2015 | 287,611.00 |
| Dec 31, 2014 | -754,378.00 |
| Sep 30, 2014 | -30,868.00 |
| Jun 30, 2014 | 262,229.00 |
| Mar 31, 2014 | 53,805.00 |